mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.005 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.005 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.006 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.006 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |